Search Results

November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).

Elizabeth Johnstone were awarded one of the 2022 Diabetes Research Grants at the World Diabetes Day Breakfast "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of

Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline

(s) Kari Johnson: mGlu2, Addiction, and the Brain Circuits Alcohol Rewires The brain circuits governing Kari Johnson's research follows this receptor from the bench to the behaving animal, using optogenetics ABOUT THE GUEST Kari Johnson is an assistant professor of neuropharmacology at the Uniformed Services Kari Johnson is currently an assistant professor at the Uniformed Services University of the Health Sciences Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.

over 20 years of experience in the medtech and diagnostics industries, having held senior roles at Johnson & Johnson and Danaher across the EMEA region in sales, marketing, and general management. Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari

She began her Ph.D. at Imperial College London with Prof Aylin Hanyaloglu, Prof Gary Frost, and Dr.